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Abstract 
STUDIES TO ELUCIDATE THE EFFECTS OF IRON(III) ON RECOGNITION OF 
HYALURONATE BY THE CELL SURFACE RECEPTOR CD44. 
Brittania J. Bintz, M.S. 
Western Carolina University (August 2006) 
Director: Dr. Jack S. Summers 
Iron and the poly-anionic carbohydrate, hyaluronate (HA) , have both been 
implicated as possible contributors to rheumatoid arthritis (RA) , an autoimmune 
disease of unknown etiology. In this work, we hypothesized that in RA patients , 
iron is bound by HA in such a way as to affect HA binding by the cell surface 
glycoprotein CD44, a known HA receptor. To test this hypothesis , we developed 
cell based assays to determine the effects of iron binding to HA on HA binding by 
CD44. As part of this effort, we prepared biotinylated HA and biotinylated Fe 
complexed HA. Mesothelioma cells expressing CD44 were treated with each of 
these conjugates , and the resulting materials were treated with avidin-fluorescein 
and the bound fluorescein was measured using a fluorescence microtiter plate 
reader. We found that Fe (III) decreases the apparent affinity of CD44 receptors 
on Mesothelioma cells for HA (Observed fluorescence intensity decreased by a 
factor of -2) . In competition experiments , addition of non-biotinylated Fe 
complexed HA did not inhibit binding of biotinylated HA. Addition of non-
biotinylated HA, however, appeared to increase the uptake of biotinylated Fe 
viii 
complexed HA. These results suggest that iron(lIl) may crosslink HA molecules, 
leading to a greater uptake of HA. This crosslinking may influence receptor 
clustering which is believed to be important to intra-cellular signaling. 
1. Introduction 
1.A. Rheumatoid Arthritis 
In general , inflammation results in an accumulation of fluid at a particular 
site in response to stimuli such as infection or trauma 1, This fluid contains 
leukocytes, in particular lymphocytes2 , As a result of inflammation , localized 
pain , redness, warmth , and swelling can occur , Chronic inflammation causes 
degradation and digestion of the extracellular matrix2, 
Rheumatoid arthritis is a chronic inflammatory disease principally 
affecting the articular cartilage of synovial jOints3, The etiology of RA is unknown, 
but progression of the disease involves autoimmunitya Symptoms of the disease 
include mild to severe pain and inflammation of synovial joints, decreased energy 
levels, and difficulty moving affected joints3,4 In RA, inflammatory fluids are high 
in T-cell concentration and accumulate within synovial joints in response to some 
unidentified trigger1,S T-cells stimulate the production of cytokines, which then 
stimulate synovial cells to release matrix metalloproteinases that cause 
degradation of the joint cartilage30 
1 
2 
1.B. Glycosaminoglycans 
Proteoglycans are complexes of small proteins covalently linked to 
polysaccharide units. These saccharide polymers are commonly called 
glycosaminoglycans (GAGs)s GAGs are composed of a repetition of specific 
saccharide pairs ; essentially a coupling of a hexosamine such as n-
acetylglucosamine or n-galactosamine to a hexauronic acid7,6. The structure of 
one such GAG, hyaluronic acid , is presented in Figure 1. Glycosaminoglycans 
are found in the extracellular matrix of articular cartilage and as cell surface 
polysaccharides7 . The GAG hyaluronic acid (HA) is the predominant GAG found 
in cartilage and is also a major constituent of synovial fluid , a viscous, lubricating 
liquid present in the joints that contains a myriad of carbohydrates, proteins and 
lipids8 . The viscosity and shock absorbing character of GAG solutions is due in 
part to the highly negative charge and high molecular weight of GAGs. These 
characteristics cause an attraction of water molecules to the surface of the 
polymer9. Conversely, water molecules are excluded from within the GAG 
matrix7,1o 
Unlike many GAGs, HA contains no sulfate7 . HA is a linear carbohydrate 
consisting of repeating disaccharide unitsJ The repeating saccharides , namely 
glucuronic acid and n-acetyl glucosamine, are linked by beta 1,3 and beta 1,4 
glycosidic likages as shown in Figure 16,7,16. 
Figure 1. Structure of the Repeating Disaccharide Unit of HA. 
HA is a carbohydrate composed of n-glucuronate (left saccharide) and n-
acetylglucosamine (right saccharide) linked by a beta 1,3 glycosidic linkage. 
o 0 
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1.C. Depolymerized HA in Synovial Joints 
Research has indicated that the hyaluronic acid found in the synovial 
3 
joints of rheumatoid arthritis patients is present in low concentrations and is of 
low molecular weight9 , It has been proposed that the fragmented HA contributes 
to the self antigenic nature of rheumatoid arthritis 18, Noble et al. have tested the 
ability of degraded and full length HA to trigger the response of NF-KB, a 
transcription factor that becomes activated during inflammation , They found that 
only low molecular weight HA elicits a response, although the mechanism is not 
known 18 , Additionally, McKee et al. discovered a myriad of inflammatory genes 
in macrophages that become activated when low molecular weight HA fragments 
accumulate10. These authors suggest that to maintain the cycle of inflammation 
in RA, a constant supply of fragmented HA must be generated 10. 
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1.0. Anemia in Rheumatoid Arthritis 
Systemic anemia generally accompanies RA. Anemia of chronic disease 
(AGO) is the most common cause for anemia in RAn Approximately 30-70% of 
RA patients are diagnosed with AG022. Although iron is present in low 
concentrations in the serum of RA patients due to AGO, the synovium contains 
high concentrations24. Iron in the synovium is bound to ferritin , an iron storage 
protein24. Additionally, there is a difference in the concentrations of iron bound to 
ferritin in the synovial fluid and the synovial membrane24. The lower 
concentration of saturated ferritin in the synovial fluid is contributed to exposure 
of the fluid to damaging superoxide free radicals and subsequent release of the 
iron from the ferritin24. 
1.E. Haber-Weiss Generation of Free Radicals 
One theory that accounts for the degradation of HA in the joints is based 
on the observation that HA is degraded by reaction with hydroxyl radicals. These 
radicals are proposed to be generated by Haber-Weiss reaction of reduced iron 
with hydrogen peroxide. Because iron is known to be present in high 
concentrations in the synovium of rheumatoid arthritis patients, it has long been 
suspected that damaging free radicals are generated by the Haber-Weiss 
reaction11 ,12,24. The Fe (II I) present in the joints reacts with superoxide (02'- ) 
giving rise to dioxygen and a reduced Fe (II) molecule that can react with 
hydrogen peroxide. When the Fe (II) reacts with hydrogen peroxide , a highly 
reactive hydroxyl radical forms. The hydroxyl radical reacts rapidly with many 
biomolecules it encounters, leading to carbohydrate damage, membrane lipid 
peroxidation, protein crosslinking , proteasomal degradation, and DNA 
fragmentation 15. This may lead to depolymerization of the matrix of joint 
cartilage. 
Figure 2. Haber-Weiss Reaction. 
0 20 ' + Fe (ll I) 
Fe (Il) + H202 
0 / + Fe (1I ) 
Fe (Ill ) + OH' + OH' 
0 / + OH'+ OH' 
1.F. CD44 Cell Surface Glycoproteins 
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CD44 is a cell surface glycoprotein that is involved in many cellular 
functions including cell communication , signal transduction , extracellular matrix 
assembly, and cell adhesion and migration 1. 2S CD44 is principally expressed on 
B cell and T cell lineages. Furthermore, CD44-hyaluronan interactions may 
function in cell-to-cell communication and in cell adhesion because of the high 
viscosity of the hyaluronan ligand25, 26 . Due to its high expression in tumor cells 
and its role in cell migration, CD44 has been implicated in metastasis2S For this 
project, mesothelioma cells were chosen for their high degree of CD44 
expression2J 
The synovial fluid in RA patients contains both CD44 cell surface 
glycoproteins and hyaluronan9. When CD44 is associated with the HA ligand, 
normal cellular function is observed2B • When the association between HA and 
CD44 is disrupted, complications arise and apoptotic pathways are induced2B. 
This disruption is proposed to playa central role in the autoimmune nature of 
rheumatoid arthritis. 
1.G. Role of GAGs in Rheumatoid Arthritis 
6 
Recent research suggests that rheumatoid arthritis is mediated specifically 
by recognition of GAGs by CD44 and CD4 T_cells5•2. In addition , an autoimmune 
reaction to GAGs was found to cause RA symptoms in synovial joints of mice, 
which correlated with the prevalence of CD4 T-cells expressing GAG-binding 
cell-surface proteinsS It has been established that CD44+ cells mediate binding 
with GAGs and are found in the synovial fluid of RA patients but not healthy 
patients 1.6 . A study conducted by Wang et al. included the use of an aluminum 
hydroxide (AI(OH3)) adjuvant that was found to exacerbate RA symptoms in the 
mouse modelss The role of this adjuvant was not considered in their results. 
7 
1.H. Hypotheses 
Because of their net negative charge, GAGs are able to bind to metal 
cations, presumably causing a conformational change of the complex . We 
propose that this change affects the recognition of GAGs by CD44 and may 
potentially have serious consequences related to rheumatoid arthritis. The role 
of the metal ion in CD44 recognition has not been studied previously. Described 
in this thesis is the development of methods to test whether the metal ion 
contributes to this decrease in recognition . 
Also described in this thesis is the development of a method to 
depolymerize HA. Depolymerized hyaluronic acid is found within the joints of 
rheumatoid arthritis patients. Depolymerized HA fragments may cause a rapid 
autoimmune response, creating a symptomatic cascade of events. Additionally, 
iron present in the joints of rheumatoid arthritis patients may preferentially bind 
lower molecular weight HA. This favored binding may increase the inflammatory 
response and antigenic recognition in rheumatoid arthritis. 
2. Experimental 
2.A. Limit of Detection Determination for Microtiter Plate Reader 
A limit of detection of the fluorescence microtiter plate reader (FLUOstar 
Optima) was established . A 5 J.Jg/mL solution of avidin-fluorescein was prepared 
and serially diluted 3: 1 to a concentration of 0.05 J.Jg/mL. HEPES buffer (1 .5 M 
NaCI, pH 8.5, 0.08% sodium azide) was used as the diluent. Samples were 
prepared, transferred to a 96-well microtiter plate , and analyzed in triplicate using 
an excitation wavelength of 485 nm and an emission wavelength of 520 nm. The 
data from three experiments were averaged, and the fluorescence intensities 
were plotted against avidin-fluorescein concentration to give a linear relationship. 
The signal to noise ratio was considered in determining the lowest detectable 
limit. The limit of detection was experimentally determined to be 0.5 J.Jg/mL of 
avidin-fluorescein. 
2.B. Cell Culturing 
2. B. 1. Preparation of Cell Culture Lab 
Animal cell culture requires specific conditions for the successful 
propagation of contaminant-free cell populations. A properly working 
microbiological safety cabinet, certified CO2 incubators, and decontaminated 
workspace are only some of things necessary for cell culture . When this project 
8 
9 
was in its initial stages, a cell culture laboratory did not exist at Western Carolina 
University. Initially, a lab was sterilized using an antibacterial alkaline detergent 
and an antifungal solution. All exposed laboratory surfaces were 
decontaminated with both cleaning solutions. The microbiological safety cabinet 
was inspected and a new HEPA filter and UV light were installed. New CO2 
incubators were installed and calibrated . 
2.8.2. Initial Cell Subculturing 
Human mesothelioma cells from ATCC (ATCC# CRL-5946; NCI# H2452) 
were maintained in the vapor phase of liquid nitrogen to prevent loss of viability 
until the culture was initiated as indicated by the supplier. Media used for 
culturing was an RPM I 1640, which contains L-amino acids, vitamins, minerals 
and buffers (13) The media was supplemented with 2mM L-glutamine as a 
carbon source adjusted to contain 1.5 gIL sodium bicarbonate , 4.5 gIL glucose, 
10 mM HEPES buffer, and 1.0 mM sodium pyruvate (90%). 
The protocol recommended by the supplier for initial subculture was used . 
The hood was sterilized by swabbing all surfaces with 70% ethanol. All supplies 
were moved into the hood following sterilization with 70% ethanol. Media was 
supplemented with 10% FBS and 1 % penicillin-streptomycin for the prevention of 
bacterial contamination . The supplemented media (15 mL) was then transferred 
to a T75 vented flask and incubated at 37"C for 15 minutes to assure that the 
media was at the proper temperature and pH. The cells were then thawed 
10 
rapidly to 37"C and the contents of the vial were added to the T75 flask making a 
final total volume of 16 mL. The flask was incubated at 37"C with 5% CO2 . The 
cells were viewed daily using an inverted light microscope to monitor cell growth 
and confluence. The media was observed to check for signs of contamination, 
including turbidity, slow cell growth, and the presence of microbial colonies. The 
media contained phenol red pH indicator with a pH range of 6.8 - 8.0 and 
appears yellow at acidic pH and fuchsia when basic. When a pH change was 
observed, the old media was removed and new media was added . 
2.8.3. Cell Passage 
Cell passage or subculturing is defined as the division of a cell culture29 . 
Cells are passaged at 80% confluence, or when the available growth substrate is 
almost completely occupied and nutrients are becoming scarce29 . The cell 
passage protocol for human mesothelioma cells was as follows . Initially, old 
culture medium was removed29 . Cells were scraped from the culture substrate 
using a cell scraper. Scraping was chosen rather than enzymatic methods to 
preserve the CD44 cell surface receptor. Six to eight mL of media was added to 
the flask and the solution was gently pipetted to disperse the cells. Aliquots of 
the suspension were then transferred into sterile T75 flasks at subcultivation 
ratios of 1:4 or 1:6 and incubated at 37"C. A complete change of media was 
conducted every 1 to 2 days. 
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2.8.4. Cryopreservation of Cells 
To safeguard against the fact that something might happen to the 
incubating cell population, stocks of additional healthy cell populations were 
stored cryogenically. Cells were fed one day prior to freezing to prevent 
unnecessary additional stress. Prior to cryopreservation , the cells were viewed 
using an inverted light microscope and inspected for signs of contamination. The 
media was removed and the cell layer was washed with 5 mL of Hanks Buffered 
Saline Solution (HBSS) to wash the cell layer for removal of traces of serum that 
could inhibit trypsin . Subsequently, 5 mL of trypsin-EDTA (at 37"C) was added 
to the flask. The culture was observed under an inverted light microscope for cell 
rounding and phase change, indications that the cells were no longer attached to 
the flask surface. This process typically took no longer than 5 minutes and was 
not allowed to proceed beyond 15 minutes because cell damage could occur. 
After 5 minutes, 5 mL of media was added and the cells were collected in a 15 
mL conical centrifuge tube. Next, a 200 ~I aliquot of the cell suspension was 
removed for cell counting (see protocol below) . The 15 mL conical tube was then 
centrifuged in a Sorvalll RC 5C at 100 x g at 4°C for 5 minutes. The supernatant 
was discarded and the pellet was resuspended in enough cryoprotective media 
to give a final concentration of 1-2 x 106 cells/mL. The cryoprotective media was 
composed of the original media supplemented with 10% DMSO. The cell 
suspensions were then transferred into cryovials and cooled at a rate of 1°C per 
minute until a final temperature of -80°C was reached. 
2.8.5. Cell Counting 
A solution was prepared that contained 0.2 mL of cell suspension (as 
described above), 0.5 mL of trypan blue (0.4%) and 0.3 mL of HBSS. The 
solution was incubated at room temperature for 5 to 15 minutes. During this 
incubation trypan blue stained the dead cells and was excluded from the live 
cells. The solution was then transferred to a hemacytometer and viable cells 
were counted using a protocol supplied by Sigma-Aldrich . 
2.C. Preparation of Samples for Competition Assays 
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The following samples were prepared in order to study the effects of iron 
(III) on recognition of HA by its cell surface receptor CD44: (1) HA, (2) Fe 
complexed HA, (3) biotinylated HA, and (4) biotinylated Fe complexed HA. 
2.C.1 . Preparation ofHA 
A solution of hyaluronic acid was prepared by adding 0.2 g Na-HA to a 
70:30 mixture of 95% ethanol/HCI (0.1 M) and stirring for 1 hour. The solution 
was then centrifuged for 5 minutes. The supernatant was removed and 
discarded. This step was done to convert the Na-HA to hyaluronic acid . The 
converted hyaluronic acid (1 .5 mg) was then added to deionized water (1.0 mL) 
and stirred overnight to assure complete dissolution. 
13 
2.C.2.a. Preparation of Fe Complexed HA: Conversion of Sodium Hyaluronate to 
HA. Preparation of the HA-Fe complex (HAFe ratios of 1: 1, 2: 1, 4: 1, 8: 1) 
included a step in which sodium hyaluronate was converted to hyaluronic acid . 
Sodium hyaluronate (0 .6 g) was added to 50 mL of a 70:30 mixture of 95% 
ethanol I HCI solution (1 .0 M, pH 2.0) and allowed to stir at room temperature for 
15 minutes. The solid was filtered off and washed with the remaining mixture of 
70:30 ethanol I 0.1 M HCI and 95% ethanol (25 mL). The samples were then 
dried in vacuo. A stock solution was prepared using the dried hyaluronic acid 
(0.51 g) dissolved in 17 mL of deionized water. The sample was heated in a 
water bath (60°C) to assure complete dissolution . Four samples were then 
prepared with HA repeating unit to Fe molar ratios of 1: 1, 2: 1, 4:1, and 8: 1. 
Fe(N03)J· 9H20 (0.1 M, 76.5 IJL) was added to each reaction tube containing 1, 
2, 4 and 8 IJL of HA solution respectively. Fe(N03)J·9H20 was chosen for its 
ease of solubility. According to Merce et al. a scant precipitate should have been 
evident upon addition of the Fe(N03h9H20Errorl Bookmark not defined .. Unlike what 
was described by Merce et aI. , no orange gelatinous precipitate was recovered . 
This preparation was considered unsuccessful. 
2.C.2.b. Preparation of Fe Complexed HA: Stirring Schedule. An additional trial 
to prepare an Fe complexed HA sample included a stirring schedule for the 
conversion of sodium hyaluronate to hyaluronic acid to determine if the duration 
of conversion affected the outcome of the synthesis of the HA-Fe. Hyaluronic 
- .- .- ---- ---- ---- -------------- --------
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acid (0.04 g) was added to 10 mL of a 70:30 mixture of 95% ethanol/HCI (0.1 
M). The solutions were stirred for periods of 5 minutes, 1 hour, 5 hours, 8 hours, 
and overnight. The solutions were then centrifuged for 15 minutes and the 
supernatant was removed . The solid was then washed with 95% ethanol/HCI 
(0.1 M) and dried under a vacuum. The remaining solid was transparent and 
adhered to the side of the conical centrifuge tube. Deionized water was added 
and the tube was placed in an 80°C water bath for dissolution of the solid . The 
sol id did not dissolve in water. Since hyaluronic acid is water soluble and Fe20 3 
is not, th is trial was aborted because insolubility in water suggested that the 
product did not contain HA. 
2.C.2.c. Preparation of Fe Complexed HA: Modified Protocol. A slightly different 
protocol from Merce et al. was used in this trial , which proved to be successful '4 
Hyaluronic acid (0.1 g) was added to acidified deionized water (33 mL, pH 4.0 
adjusted with HN03) and stirred for 5 minutes. This step allows for the 
conversion of the Na-HA to hyaluronic acid. Aqueous Fe(N03h '9H20 (283 IJL, 
0.1 M) was added to the solution. Immediately a large amount of opaque, 
gelatinous, threadlike precipitate formed . The pH was adjusted once again to 3.0 
using HN03 to prevent precipitation of the Fe and to facilitate dissolution of the 
remaining solid Na-HA. As the pH was reduced the gelatinous precipitate 
dissolved. The solution was stirred for approximately 1 week. The solution was 
then buffered to a physiological pH (6.5 - 7.2) using PIPES buffer (0.6 g PIPES, 
15 
3 mL NaOH). Upon addition of the PIPES the solution turned clear yellow with 
no visible precipitate. Ethanol was then added to precipitate the complex. A total 
of 250 mL of ethanol was needed for precipitation. The precipitate was 
gelatinous and yellow. The sample was stored at -20·C overnight to allow 
complete precipitation of the complex. The solution was then divided into 15 mL 
conical centrifuge tubes and centrifuged for 30 minutes (with a Sorvall HS-3000 
rotor). The supernatant was removed and discarded. A total of 0.1193 g of 
product was recovered. A small amount of the solid (2.5 mg) was added to 1.5 
mL of deionized water to determine if the solid was soluble in water. If the solid 
was not soluble it may suggest that it was Fe20 3. The solid was soluble in water 
and the solution appeared light yellow in color. 
For characterization , 0.062 g of solid was dissolved in 1.5 mL deionized 
water. The solution was placed in a 0.45 IJm microspin column and centrifuged 
for 10 minutes at 10,000 rpm. The resulting filtrate appeared to be yellow 
suggesting that the Fe passed through the filter, which indicated that it was 
bound by the carbohydrate. If the Fe was present as Fe20 3 it would not have 
passed through the filter. To further characterize the complex, the filtrate was 
placed in a 10,000 MWCO microspin column and centrifuged for 10 minutes at 
10,000 rpm . The retentate was yellow in color and the filtrate was clear. This 
suggested that the Fe did not pass through the column and was therefore 
attached to the high molecular weight carbohydrate which was unable to pass 
though the filter. UV-vis analysis results showed maximum absorbance for 
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Fe(N03h at approximately 285 nm, while the Fe complexed HA did not display a 
similar maximum absorbance. Additionally, Fe complexed HA (1 .5 mg) was 
dissolved in deionized water (10 mL) and analyzed for iron content using ICP-
OES. ICP results showed that a 1.5 mg sample contains 0.01762 mg of iron. 
2.C.3.a. Preparation of Biotinylated HA. HA was biotinylated using commercially 
available EZ-link biotin hydrazide (Pierce) according to the supplier's protocol 
(Figure 3). First, a carbohydrate solution was prepared by dissolving hyaluronic 
acid in ammonium acetate coupling buffer (2 .0 mg/mL; pH 5.5) . Cold sodium 
metaperiodate (20 mM; 1 mL) was added to the solution of hyaluronic acid (1 
mL) and the oxidation reaction was allowed to proceed for 30 minutes at 4°C in 
the dark. Glycerol was added to the reaction mixture at a final concentration of 
15 mM to stop the oxidation . The resulting solution was dialyzed overnight 
against ammonium acetate coupling buffer using a Slide-A-Lyzer dialysis 
cassette 10K MWCO (Pierce). Then , biotin hydrazide was added at a final 
concentration of 5 mM and stirred at room temperature for 2 hours. The 
hydrazide group reacts with any carbonyl groups formed during the oxidation 
reaction to form the linkage. Following the incubation, the biotinylated molecule 
was separated from unreacted biotin hydrazide using an additional overnight 
dialysis. 
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Figure 3. Periodate Oxidation and Biotinylation of Hyaluronic Acid (HA). 
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2.C.3.b. Characterization of Biotinylated HA. To ensure that the synthetic 
protocol was successful , the aforementioned biotinylated HA samples were 
characterized using a fluorescence microtiter plate reader. A solution of avidin-
fluorescein in HEPES buffer (0.15 M NaCI, pH 8.5, 0.08% sodium azide) was 
prepared at a final concentration of 20 ~g/mL. Then , a solution of avidin-
fluorescein and biotinylated HA was prepared by adding 100 ~I of avidin-
fluorescein (20 ~g/mL in HEPES buffer) to 100 ~I of biotinylated HA (1 .5 mg/mL). 
The solution was stirred for 1 hour at room temperature. This protocol was 
performed a total of 3 times . Each solution of avidin-fluorescein with biotinylated 
HA was characterized as described below. 
A precipitation experiment was used to confirm that (1) biotin was linked to 
HA and (2) avidin-fluorescein bound to biotinylated HA. Only HA and 
compounds bound to HA should precipitate. Intially, 1 00 ~I of the samples 
prepared above were diluted in 100 ~I of HEPES buffer to equal the 
concentration of the biotinylated HA with avidin-fluorescein . The samples (100 
~ I ; 0.075 mg HA) were then added to microcentrifuge tubes with ethanol (1 mL, 
4°C) and vortexed . The samples were centrifuged at 10,000 rpm (with a Sorval 
SH-3000 rotor) for 30 minutes. The supernatant was removed and the remaining 
precipitate was washed with ethanol (4°C) . The samples were centrifuged once 
again and the supernatant removed . The resulting precipitates were 
reconstituted in HEPES buffer (500 ~I ; 0.15 M NaCI, pH 8.5, 0.08% sodium 
azide). Avidin-fluorescein that did not undergo the precipitation protocol was 
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used as a control , as well as a sample of avidin-fluorescein that did undergo the 
precipitation reaction . The samples and controls were analyzed using a 
microtiter plate reader. 
Samples of precipitated biotinylated HA with avidin-fluorescein and the 
untreated avidin-fluorescein control were expected to give high fluorescence 
intensities. The results of th is procedure were consistent with the presumption 
that biotin was indeed conjugated to the HA. Fluorescence was observed in the 
wells containing biotinylated HA with avidin-fluorescein and also in the wells 
containing the untreated avidin-fluorescein . The wells containing avidin-
fluorecein did not show fluorescence, indicating that this sample was not 
precipitated by ethanol. These results indicate that the compound synthesized 
was actually biotinylated HA. Additionally, this experiment also proved that 
biotin , when conjugated to HA, was able to bind to avidin-fluorescein in solution . 
The ratio of biotin to HA repeating unit was not determined. 
2. C. 4. Preparation of Biotiny/ated Fe Comp/exed HA 
A complex of biotinylated Fe complexed HA was synthesized . Biotinylated 
HA (prepared as described above) (3 mL, pH 5.5) was added to solid 
Fe(N03h'9H20 (1.5 mg/mL). After vortexing , the pH was adjusted to 7.0 using 
PIPES buffer (117 IJL) and the solution was stirred overnight at 37"C. A heavy 
orange precipitate formed . The solution was centrifuged through a 0.45 IJm filter. 
Since Fe20 3 cannot pass through a 0.45 IJm filter, it was assumed that the light 
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yellow filtrate contained the Fe complexed biotinylated HA and not Fe20 3. The 
sample was analyzed for iron content using ICP-OES. A sample was prepared 
for ICP-OES by diluting 100 1-11 of the Fe complexed biotinylated HA in 10 mL of 
deionized water. ICP results suggested that the iron content of the sample was 
below the limit of detection of the instrument. However, because the solution 
was yellow in color, iron was present. 
2.0 . Assay Development: Detection of CD44 Binding of HA 
2.0.1. Fluorescence Quenching by Fe (III) Assay 
Potentially, the fluorescence of fluorescein could be quenched by Fe 
bound to HA. Samples were prepared that contained a consistent concentration 
of avidin-fluorescein (5 I-Ig/mL, 6 I-II) but varying concentrations of biotinylated HA 
and biotinylated Fe complexed hyaluronic acid. Reagent volumes are listed in 
Table 1. The total reaction volume was 150 I-IL per well. Reagents were placed 
into wells of a black microtiter plate for reduction of fluorescence crosstalk 
between wells. Analysis of fluorescence signal was accomplished using a 
fluorescence microtiter plate reader. All samples were read in duplicate. If 
quenching occurred , fluorescence would decrease as the concentration of 
biotinylated Fe complexed HA increased. 
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Table 1. ReaQents Added for Fluorescence Quenching by Fe (III ) Assay. 
Sample Avidin HA"-Fe [1 .5 HA" [1 .5 HEPES 
Fluorescein mg/mL] ( ~L) mg/mL] (~L ) Buffer (~L) 
Cull 
Blank 0 0 0 150 
Positive Control 6 0 0 144 
Sample #1 6 40 0 104 
Sample #2 6 20 20 104 
Sample #3 6 10 30 104 
Sample #4 6 5 35 104 
' Denotes blotlnylatlon of the sample. 
2.0 .2. Confirmation of C044 Expression Using l ' and 2' Antibodies 
Antibodies specific to CD44 cell surface glycoproteins were used to 
confirm the expression of the extracellular CD44 molecule. Mesothelioma cells 
were seeded into a white 24 well microtiter plate at 5000 cells per well. The cells 
were allowed to incubate for 24 hours at 37'C with 5% CO2. The 24 hour 
incubation allowed for re-expression of the CD44 molecule in the event that 
damage to the receptor had occurred during cell passage, while maintaining a 
relatively low confluence. High cell confluence in fluorescence assays gives a 
false low fluorescence signal. A primary mouse monoclonal antibody (abCam, 
ab6337) to CD44 was diluted 1: 1 00 in PBS with 3% BSA and incubated with the 
mesothelioma cells for 20 minutes at room temperature . The cells were then 
washed three times, for 3 minutes per wash, in PBS with 3% BSA. A secondary 
rabbit polyclonal antibody to mouse IgG conjugated to Texas Red was 
diluted1 :100 in PBS with 3% BSA. The cells were incubated with the secondary 
antibody for 15 minutes at room temperature, and then washed three times in 
PBS. The fluorescence was detected at an excitation wavelength of 584 nm and 
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an emission wavelength of 612 nm using a fluorescence microtiter plate reader. 
A slight increase in fluorescence was detected and an additional incubation with 
a 1: 1 0 dilution of secondary antibody was conducted for 15 minutes at room 
temperature. The fluorescence signal increased slightly, indicating that the 
primary antibody was able to bind to the CD44 molecule. Based on the slight 
increase in fluorescence, it was believed that the incubation times weren 't 
sufficient enough to allow complete association of the CD44 molecules with the 
antibodies. In future assays the incubation times were increased to 30 minutes 
as indicated by Harlow et al.20 The cells were then incubated for 30 minutes at 
room temperature with Hoescht dye. Hoescht dye binds DNA at the minor 
groove and has a fluorescence maximum at 460 nm when bound to DNA. 
Hoescht staining provides evidence for continuity in cell confluence among the 
wells. 
2.0.3. Confirmation of CD44 Expression by Antibody Blocking 
Primary antibodies were employed to verify that CD44 was being 
expressed on the surface of the mesothelioma cells and that hyaluronic acid was 
binding to the CD44 receptor. An anti-CD44 mouse monoclonal antibody 
(abCam, ab6337) was chosen for its specificity to the CD44 receptor. No 
literature exists on the epitope of this antibody. If the antibody does bind to the 
receptor directly it may block any subsequent HA from binding . If this is the 
case, upon addition of biotinylated HA to cells that had been pre-incubated with 
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CD44 antibody, a reduction in the fluorescence signal would be observed 
compared to cells incubated with only biotinylated HA. These results would 
indicate that CD44 is being expressed by the cells and that both the antibody and 
the biotinylated HA are binding to the same region of the receptor. 
Mesothelioma cells were seeded into a white , 96 well microtiter plate at 
500 cells per well . The cells were allowed to incubate at 37"C with 5% CO2 for 24 
hours. The anti-CD44 antibody was diluted 1:100 in PBS with 3% BSA. The 
diluted antibody (40 ~I) was added to the cells and incubated for 30 minutes at 
room temperature. The cells were washed 3 times for 3 minutes in PBS with 3% 
BSA (250 ~I) . Biotinylated HA (1 .5 mg/mL, 40 ~I) was added to the wells and 
incubated for 30 minutes at 37"C, and washed in PBS with 3% BSA (250 ~I , x3 
for 3 minutes each wash). Additionally, wells were incubated with biotinylated 
HA and no antibodies for use as a comparison of fluorescence signal. The cells 
were then fixed by incubating in paraformaldehyde (40 ~I ; 4 %) for 10 minutes at 
room temperature. The wells were washed with PBS with 3% BSA (250 ~I , x3 for 
3 minutes each wash) . Fixing did not alter the morphology of the CD44 receptor 
as seen in section 2.DA.b. All of the wells were incubated for 30 minutes at 
37°C with avidin-fluorescein (20 ~g/mL , 40 ~I) , and washed in PBS with 3% BSA. 
The fluorescence intensity was detected using a fluorescence microtiter plate 
reader. The cells were then stained with Hoescht dye for confluence analysis. 
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2.o.4.a. Depletion Assay with Live Cells. An assay was conducted in which a 
depletion in the fluorescence signal of avidin-fluorescein after incubation with 
mesothelioma cells was compared to the increased fluorescence signal of the 
cells. This data helped determine the extent of avidin-fluorescein binding to the 
biotinylated HA and whether the fluorescence signal was high enough above 
background to be detected. Mesothelioma cells were seeded into a white, 96 
well microtiter plate at 500 cells per well. The cells were allowed to incubate for 
24 hours at 37"C with 5% CO2 . The media was removed and the cells were 
washed with PBS. Biotinylated HA (1 .5 mg/mL, 40 1-11) was added to the wells 
and allowed to incubate for 30 minutes at 37°C. The cells were washed with 
PBS. Avidin-fluorescein (20 I-Ig/mL, 40 1-11) was added and the cells were allowed 
to incubate for an additional 30 minutes at 37°C. The avidin-fluorescein from the 
well which was initially incubated with biotinylated HA was then transferred to an 
empty well and fluorescence was analyzed using a fluorescence microtiter plate 
reader. The cells were then incubated with Hoescht dye for 30 minutes at room 
temperature for confluence analysis . 
If avidin-fluorescein is bound to biotinylated HA and the HA is bound to 
CD44, the fluorescence of the transferred avidin-fluorescein should be lower than 
the fluorescence of a stock solution of avidin-fluorescein. As a control, avidin-
fluorescein was added and then removed from a well which was then washed to 
demonstrate that the fluorescence signal was not due to traces of avidin-
fluorescein left in the well after washing . It was evident from the data that the 
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washing protocol was sufficient. Additionally, an increase in fluorescence in the 
well that was incubated with biotinylated HA and avidin-fluorescein was 
expected. The results indicated that avidin-fluorescein was binding to 
biotinylated HA, which was bound to CD44 expressed by the mesothelioma cells. 
2.D.4.b. Depletion Assay with Fixed Cells. Because subsequent assays were 
lengthy, cell viability was a concern. One method used to circumvent 
questionable viability during a cell-based assay is cell fixation . Two different 
techniques for cell fixing include the use of organic solvents and the use of 
formaldehyde and its derivatives for protein crossiinking20 In general , methods 
that employ organic solvents tend to dehydrate the cell , altering lipid 
composition20 Crosslinking agents like paraformaldehyde maintain the cellular 
morphology but may modify epitope regions of receptors20 However, 
modification can be reversed by incubation with proteases20 For this assay, 
paraformaldehyde was chosen because of the low potential for morphological 
modification. During cell fixation with paraformaldehyde, extracellular protein 
matrices become cross-linked and "fixed" in place while carbohydrates, lipids and 
nucleic acids remain virtually unaitered20 
Preparation of paraformaldehyde included dissolution of the solid (0.8 g) in 
deionized water (10 mL) with NaOH at 60·C. Dissolution of paraformaldehyde 
results in an aqueous solution of methylene hydrate which reacts chemically in 
the same manner as gaseous formaldehyde in cell fixing 19. The solution was 
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cooled to room temperature and 2X PBS was added (10 mL). This depletion 
assay was conducted similar to the initial depletion assay with the exception that 
the cells were fixed prior to incubation with avidin-fluorescein . The fixing step 
included incubation of the cells in paraformaldehyde (40 ~I , 4% solution) for 10 
minutes at room temperature . After the fluorescence was analyzed using a 
microtiter plate reader, the cells were then stained with Hoescht dye for analysis 
of cell confluence . Add itionally, these assays provided insight into the 
optimization of the cell based assay. Incubation times, wash steps, and the fixing 
protocol were optimized . 
2.0.5. Competition Assay 
Competition experiments were conducted to determine the effects of Fe 
on HA binding by CD44. In these experiments, the competing reactants (ie, 
either Fe complexed HA and biotinylated HA, or HA and biotinylated Fe 
complexed HA) were added to microtiter plate wells containing the mesothelioma 
cells. The uptake of the biotinylated reactant was measured by its ability to bind 
the fluorescently labeled avidin. Experiments in this series are described below. 
A competition assay was conducted to determine if metal complexed HA 
binds to CD44 receptors with less affinity than HA. Because HA molecules are 
polyanions, the presence of the metal cation could cause crosslinking among 
normally linear HA chains. Two crosslinking reactions were conducted in which 
biotinylated HA and Fe complexed HA were added to a microcentrifuge tube and 
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incubated for 30 minutes at room temperature. Similarly, HA and biotinylated Fe 
complexed HA were added and incubated in the same manner. 
2.D.5.a. Characterization of HA Binding. The binding patterns of biotinylated HA 
and biotinylated Fe complexed HA were each measured in separate 
experiments. In these experiments 40 III aliquots of the two reactants (1 .5 
mg/ml) were separately added to wells containing mesothelioma cells and the 
solutions were incubated for 30 minutes at 37"C. 
2.D.5.b. Competition Reactions. Competitive reagent samples were prepared in 
two ways: either by simultaneously mixing the reagents with the mesothelioma 
cells, or by mixing the competitive reactants and allowing them to incubate for 30 
minutes prior to their introduction to the cells. In a typical competition 
experiment, biotinylated HA (1 .5 mg/ml, 40 ~I) and Fe complexed HA (1 .5 
mg/ml, 40 ~I) were added to a well simultaneously, as were HA (1 .5 mg/ml, 40 
~I) and biotinylated iron complexed HA (1.5 mg/ml, 40 ~I) . 
2.D.5.c. General Procedures. All reactions were conducted in duplicate. 
Mesothelioma cells were seeded into a white, 96 well microtiter plate at 500 cells 
per well and incubated at 37°C at 5% CO2 for 24 hours. The crosslinked 
samples were added to separate wells of the microtiter plate. Following 
incubation with a biotinylated reactant , the reagents were removed and the cells 
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were washed in PBS (x3 for 3 minutes each wash). The cells were then 
incubated in 4% paraformaldehyde (40 IJI) for 10 minutes at room temperature for 
fixing . The paraformaldehyde was removed and the cells were washed again . 
Avidin-fluorescein (20 IJg/mL, 40 IJI) was added to each well and allowed to 
incubate for 30 minutes at room temperature. Again, the reagent was removed 
and the cells washed . PBS (40 IJI) was added to each well. The fluorescence 
was detected using a microtiter plate reader. The cells were then stained with 
Hoescht dye for confluence analysis. 
2.E. Depolymerization Studies 
2.E.1. Current Work with Oepo/ymerized HA 
The depolymerization of HA and the effects in rheumatoid arthritis is 
currently under investigation in the laboratories of Jack Summers and Lori 
Seischab. For this thesis project, a protocol was developed for depolymerization 
of HA using chemical and enzymatic methods. The project was assumed by 
Carmen Batchelor, who is currently seeking to quantify saccharide chain length 
of the degraded HA using electrospray ionization mass spectrometry (EI-MS) . 
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2.E.2. Depolymerization of HA 
Two different methods were used to depolymerize HA. Initially, several 
trials of a chemical digestion using HCI and heat was used. Digested samples 
were analyzed for extent of depolymerization using NMR and EI-MS. We were 
unable to provide sufficient chemical digestion by this method and have 
abandoned it in favor of an enzymatic method employing hyaluronidase. The 
depolymerized polysaccharides were analyzed by Jack Summers with nuclear 
magnetic resonance (NMR) and EI-MS. 
2.E.3. Chemical Depolymerization of HA: Short Incubation and NMR Analysis 
Solutions of HA were prepared by Lauren Rodgers. The solutions were 
placed in a 70D C water bath for durations of 6, 12, 24, 48, 72 and 96 hours. 
Different times were used to determine the length of incubation that gives the 
optimal range of depolymerization. 
Reaction tubes of depolymerized HA (250 iJL from 6 and 96 hour time 
aliquots respectively) were prepared for NMR F- relaxation studies. The original 
pH was 10 due to Na2CO:;lNaHC03 buffer present in the solution. The solution 
was acidified to pH 2.5 by addition of HCI (62.5 iJL, 1 M) to prevent immediate 
precipitation of Fe(N03)J·9H20 . Fe(N03)J'9H20 (0 .1 M, 10 iJl) was added to the 
solution at a final concentration of 1 mM. The solution was allowed to stir for 10 
minutes at room temperature. Following the 10 minute reaction period, NaF 
(0 .1 M, 200 iJl) was added at a final concentration of 20 mM. The solution was 
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brought to pH -5 using succinate buffer and the total volume was brought up to 1 
mL using deionized water. Samples were also prepared with Fe concentrations 
of 2.0 mM and 3.0 mM. The Fe was not soluble at higher concentrations. Table 
2 shows the concentrations and quantities of the reagents for all NMR analyses. 
Additional samples were prepared for longer depolymerization . 
Table 2 R eagent c oncentratlons an dQ uantJtJes or - e axatlon f F R I 5 udies. t 
REAGENT 1 mM Fe 2 mM Fe 
(conc.lquantity) (conc.lquantity) 
Fe(NO,h '9H,O 0.1M/10 ~L 0.1 M/22 ~L 
NaF 0.1 M/200 ~L 0.1 M/220 ~L 
Oepolymerized HA 250 ~L 250jJL 
Hel 1 M/62.5 uL 1 M/62.5 UL 
Succinate Buffer 387.5 uL 445.5 uL 
NaOH 90 uL 100 UL 
2.E. 4. Chemical Oepolymerization of HA: Long incubation and NMR Analysis 
An additional digestion was run to optimize the protocol for chemical 
depolymerization and for additional NMR relaxation analysis. Microcentrifuge 
tubes were prepared by dissolving 6 mg of HA in 1.5 mL of HCI (0.01 M). The 
tubes were incubated at 70·C for 0, 1, 2, 4, 8 and 16 days. Upon removal from 
the water bath the tubes were stored at -20· C. NMR reactions were prepared as 
described in the previous section. Samples were prepared with Fe 
concentrations of 0, 0.5, 1, 1.5 and 2.0 mM respectively. Table 3 shows the 
reagent concentrations and quantities for all reactions. The total reaction volume 
was 1 mL. The samples were then transferred to NMR tubes (560 ~L) and D20 
31 
(60 ~L) was added. After standing in NMR tubes overnight, each sample 
contained an orange precipitate. This observation suggested that the 
thermodynamic minimum was Fe203. NMR analysis was not conducted . 
T bl 3 R a e eagen tC t f oncen ra Ions an d Q ff f F R I f St d' uan lies or - e axa Ion u les. 
REAGENT OmM Fe 0.5mM Fe 1 mM Fe 1.5 mM Fe 2.0 mM 
(conc.1 (conc.! (conc.! (conc.! (conc .1 
quantity) quantity) quantity) quantity) quantity) 
Fe(N03h'9H,O 0.1M/O ~L 0.1M/5 ~L 0.1M/10 0.1M/15 0.1 M/20 
~L ~L ~L 
NaF 0.1 M/200 0.1 M/200 0.1 0.1 0.1 
~L ~L M/200 ~L M/200 ~L M/200 
~L 
Oepolymerized HA 250 ~L 250 ~L 250 ~L 250 ~L 250 ~L 
Hel 1 MI 63 ~L 1 MI 63 ~L 1 M/63 1 M/63 1 M/63 
~L ~L ~L 
Succinate Buffer 567 ~L 562 ~L 557 ~L 552 ~L 547 ~L 
NaOH 100 ~L 100 ~L 100 ~L 100 ~L 100 ~L 
. . 
No samples were analyzed due to Insolubility of Fe . 
2.E.5. Chemical Depolymerization of HA: Long Incubation and EI-MS Analysis 
Mlcrocentrifuge tubes were prepared that contained 6 mg of Na-HA and 
1.5 mL of HCI (0.1 M). They were incubated in a 70· e water bath for varying 
time periods. The samples were digested for 5, 8, 10, 15 or 20 days. The 5 day 
sample was then lyophilized using a centrivap concentrator. The resulting solid 
was reconstituted in a buffer mixture of 10 ~M NH40H: 10 ~M formic acid. The 
solution was analyzed for extent of depolymerization using EI-MS. The spectra 
gave one large peak with a mass to charge ratio (m/z = 380) that was too low to 
be the dimer unit. We interpreted this result as indicating that the digestions 
were not sufficient to give products small enough for analysis by EI-MS. 
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2.E.6. Enzymatic Depolymerization using Hyaluronidase: Protocol Adapted from 
Saad et al. 
Digestions were performed using bovine testicular hyaluronidase (Sigma-
Algrich) . The protocol for degradation was adapted from Sa ad et al. to determine 
if a protocol for bacterial hyaluronidase (from Streptococcus dysgalactiae) would 
be successful for bovine testicular hyaluronidase21. Microcentrifuge tubes were 
prepared at 1 mg/ml of HA as described by Sa ad et a121. A 15 IJg aliquot of HA 
was added to 40 IJl of sodium acetate buffer (pH 7.5) and 5 IJU of hyaluronidase. 
The reaction was incubated at 3rC for 15 minutes, 30 minutes, 1 hour, 2 hours, 
4 hours and 8 hours. The digestion was then quenched by adding 750 IJl of 
methanol and 710 IJl of water to the reaction tube. EI-MS analysis indicated that 
degradation of the HA did not occur. It was determined that the protocol was not 
sufficient for bovine testicular hyaluronidase. A higher concentration of the 
enzyme was necessary for depolymerization. 
2.E. 7. Enzymatic Depolymerization using Hyaluronidase: Protocol Adapted from 
Tawada et al. 
A protocol for digestion of HA was adapted from Tawada et al14 Initially, 
stock solutions of HA and bovine testicular hyaluronidase were prepared . A 
stock solution of HA was prepared by dissolving 0.2 g of HA in 50 ml of 0.01 M 
ammonium acetate buffer to give a final concentration of 4 mg/mL. The final pH 
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of the solution was 6.5. A stock solution of hyaluronidase was prepared at a 
concentration of 0.020 g/mL. Reactions were prepared by aliquoting 1 mL of the 
stock HA solution into 4 microcentrifuge tubes . The protocol by Tawada et al. 
called for 40 U of hyaluronidase per 4 mg of HA. The enzyme was added at the 
concentrations of 40, 10, 5 and 2 U. Different enzyme concentrations were used 
to determine which would give the best range of degradation of the carbohydrate. 
The microcentrifuge tubes were incubated at 37"C for one hour and boiled to 
stop the reaction . Characterization of the depolymerized HA was performed by 
Carmen Batchelor. 
3. Results and Discussion 
3.A. Assay Development: Detection of CD44 Binding of HA 
Several experiments were conducted to optimize conditions for the cell 
based competition assay. Results of the following experiments are described in 
the sections as referenced below. 
Biotinylated HA was characterized as per section 3.A.1. A precipitation 
reaction was performed to confirm that HA was present in the samples. Avidin-
fluorescein was then added to confirm that the HA was biotinylated . 
Fluorescence was analyzed using a microtiter plate reader. 
In section 3.A.2 we describe the results of an experiment to confirm that 
Fe was not quenching the fluorophore. If the fluorophore was quenched by Fe, 
other detection methods would need to be developed. 
Section 3.A.3 describes the results of experiments to confirm the presence 
of the CD44 receptor on the surface of the cells . A primary antibody to CD44 
and a secondary antibody conjugated to a fluorophore were incubated with the 
mesothelioma cells. The presence of a fluorescence signal would indicate that 
both antibodies were bound to their antigens, thus confirming the presence of 
CD44. 
Section 3.AA describes the results of an experiment conducted to confirm 
that HA was recognized by the CD44 receptor despite biotinylation of HA. An 
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anti-CD44 primary antibody was used to block the receptor from biotinylated HA. 
A decrease in fluorescence was observed between the wells in which only 
biotinylated HA was added and those wells in which primary antibody was added 
in addition to biotinylated HA. The results indictated that HA was bound to cells 
via CD44. 
Section 3.A.5 describes an experiment demonstrating that biotinylated HA 
that was bound to CD44 could associate with avidin-fluorescein , and that 
fluorescence of the complex was detectable. A depletion assay with live cells 
compared the fluorescence signal of avidin-fluorescein after incubation with 
biotinylated HA-bound cells to the fluorescence signal of the cells . The cells 
displayed an increase in fluorescence while the avidin-fluorescein displayed a 
decrease in fluorescence. The same experiment was then performed using fixed 
cells. The results indicated that cell fixing does not interfere with CD44 I HA 
interactions. 
3.A.1. Characterization of Biotinylated HA 
Upon addition of ethanol to solutions containing either biotinylated HA or 
biotinylated HA with avidin-fluorescein , a gelatinous precipitate formed . No such 
precipitates were observed when ethanol was added to avidin-fluorescein , 
indicating that the HA was necessary for precipitation. These precipitates were 
isolated and dissolved in HEPES buffer. The fluorescence intensities of the 
resulting solutions were measured (Table 4) . Fluorescence was not detected in 
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the wells that contained biotinylated HA alone because no reaction was 
conducted to link avidin-fluorescein to the biotinylated HA, therefore no 
fluorophore was present in the wells . The sample that contained biotinylated HA 
with avidin-fluorescein fluoresced as expected since the fluorophore precipitated 
with the addition of ethanol because it was linked to the carbohydrate. 
The stock solution , at a known concentration of 5 ~g/mL avidin-fluorescein 
was far more concentrated than the avidin-fluorescein present in the sample of 
biotinylated HA with avidin-fluorescein . Since the avidin-biotin association is 
assumed to occur with high efficiency, the low level of fluorescence in these 
samples was likely the result of either relatively low levels of biotin on the HA, or 
low efficiency of the precipitation. The extent of HA biotinylation is unknown. 
The sample that contained avidin-fluorescein but not biotinylated HA did 
not precipitate and therefore, showed little fluorescence. The fluorescence 
reported for this sample (Table 4) is likely due to residual avidin-fluorescein 
present in the wells. The precipitation of the biotinylated HA with avidin-
fluorescein coupled with a fluorescence intensity of the dissolved precipitate 
proves that HA was indeed biotinylated. Additionally, this data proves that HA 
was not preventing the association between biotin and avidin . 
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a e T bl 4 Ch t ° f arac erlza Ion 0 f S o f it d HA 10 myla e 
HA' HA' Av-FI Av-FI (ppt.) Av-FI stock (no 
(ppt.) ppt.) + cntrl 
Fluorescence -12 484 307 53665 
signal (AU) 
' Denotes those samples that have been blotlnylated . 
3.A.2. Fluorescence Quenching by Fe (III) Assay 
A decrease in the fluorescence intensity was observed as the 
concentration of biotinylated Fe complexed HA was increased in the presence of 
solutions of avidin-fluoresein . However, the fluorescence intensity for all of the 
samples was higher than that of the control. It has been previously established 
that an increase in viscosity of a sample and the binding of a fluorophore to a 
large molecule increases the quantum yield and thus increases fluorescence 
intensityH We attribute the increase in fluorescence to be due to the high 
viscosity of our HA solutions and to the presence of high molecular weight HA, 
which is bound to fluorescein . Furthermore, not all of the biotinylated Fe 
complexed HA will bind to fluorescein . The presence of free biotinylated Fe 
complexed HA in the sample is proposed to contribute to additional quenching. 
In the absence of free Fe complexed HA, we would expect higher fluorescence 
intensities. 
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Ta bl FI e 5. uorescence QuenchinQ. 
Sample Fluorescence 
(AU I 
Positive Control 57 
401'1 HA'·Fe J 0 1'1 HA' 67 
201'1 HA'·Fe J 20 1'1 HA' 88 
101'1 HA'·Fe J 30 1'1 HA' 100 
51'1 HA'·Fe J 451'1 HA' 96 
3.A.3. Confirmation of CD44 Expression Using 1° and 2° Antibodies 
Results of histochemical staining experiments indicate that CD44 
receptors are being expressed by the mesothelioma cells and that the CD44 
receptors bind HA and Fe·HA. In this experiment, the cells were treated with 
anti·CD44 antibodies followed by fluorescently labeled secondary antibodies. 
The secondary antibodies bound to the Fc region of the primary antibodies, 
indicating the presence of the CD44 receptors. Furthermore, the fluorescence 
signal increased when the concentration of secondary antibody increased. From 
this evidence we conclude that the cell seeding protocol was effective. To 
prevent damage to the receptors, cell scrapers were used to detach the cells 
from the cell culture substrate instead of trypsin digestion . We found that a 24 
hour incubation was sufficient for the cells to re·express the receptors damaged 
during the seeding process. 
fi Table 6. Histochemical Con Irmation of CD44 Expression. 
1° antibody + 2° 1° antibody + 2° 
Antibody (1 :100) Antibody {1 :10) 
Fluorescence (AU) 97 100 
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3.A.4. Confirmation of CD44 Expression by 1 ° Antibody Blocking 
To confirm that CD44 on the cells is the species responsible for binding 
HA, we measured the effect that treatment with anti-CD44 antibody has on HA 
binding . The reduction in fluorescence signal between wells containing similar 
reagents indicates that the primary antibody is binding directly to the receptor, 
preventing the HA from binding. Additionally, the data suggests that the Fe 
complexed HA binds to CD44 with lower affinity than the HA since the wells that 
contain Fe complexed HA have much lower fluorescence intensities. 
T bl 7 C f a e on Irmation 0 fCD44 E xpresslon )y ntl oly oc mg, b A 'b d BI k' 
HA-Fe* HA* 1° antibody 1° antibody 
+ HA-Fe* + HA* 
Fluorescence 46 100 4 45 
(AU) 
• Denotes those samples that have been blotlnylated . 
3.A.5. Depletion Assay with Live Cells 
We conducted depletion assays to evaluate the CD44 I biotinylated HA 
interaction using avidin-fluorescein binding . Cells were treated with biotinylated 
HA followed by aliquots of a stock avidin-fluorescein solution , and the amount of 
avidin-fluorescein removed from the stock solution was determined. Residual 
avidin-fluorescein (determined in control experiments) was not sufficient to give 
false positive results. The fluorescence intensity of the positive samples was 
about 7 times that of the control background . This is concluded to be high 
enough above background to be detectable in future assays. The well conta ining 
the transferred avidin-fluorescein shows a 6% depletion in the fluorescence 
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signal when compared to the well containing the avidin-fluorescein stock solution. 
The signal from the well containing the biotinylated HA with avidin-fluorescein is 
4% that of the well containing the avidin-fluorescein stock solution. Furthermore, 
the fluorescence data from the well containing the biotinylated HA with avidin-
fluorescein and the well containing the transferred avidin-fluorescein sum to 
98%, suggesting that avidin-fluorescein is binding to biotinylated HA which is in 
turn bound to the CD44 receptor. A 2% loss can be contributed to residual 
avidin-fluorescein remaining in the well after the contents were transferred and 
the well was washed. 
a e eple Ion T bl 8 D I f A ssay WI Ive e s. 'th L' C II 
HA· + Av-FI Av-FI Av-FI from Av-FI Stock 
+ cells removed + well 2 Soln. 
cells 
Fluorescence 4 0.6 94 100 
• Denotes those samples that have been blotlnylated. 
3.A.6. Depletion Assay with Fixed Cells 
Results of depletion assays with fixed cells were similar to those obtained 
from the depletion assay with live cells (Table 9) . This suggests that future 
assays can be conducted using a step that fixes the cells with paraformaldehyde 
without jeopardizing the results. All future assays will be conducted in such a 
manner that cells are fixed prior to incubation with avidin-fluorescein . 
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a e e p letlo n T bl 9 D I' A ssay Wit Ixe e s. 'hF' de II 
HA' + Av-FI Av-FI Av-FI from Av-FI Stock 
+ cells removed + well 2 Soln. 
cells 
Fluorescence 3 1 94 100 
(AU) 
* Denotes those samples that have been blotlnylated. 
3.A. 7. Competition Assay 
When analyzing the wells in which biotinylated Fe complexed HA was 
added alone, we expected to see values similar to those obtained in the 
fluorescence quenching experiment for the sample containing 100% Fe 
complexed HA (section 3.A.2) . The results show a slight reduction in the 
fluorescence intensity for the competition assay, which suggests that CD44 
receptors are not being saturated with the biotinylated Fe complexed HA. 
Additionally, comparison of the relative fluorescence of the wells treated 
with Fe complexed HA (49) to those treated with HA (92) shows a decrease in 
fluorescence intensity for the iron treated samples. We also note a decrease in 
the relative fluorescence for the incubated samples (61 and 88) when compared 
to the samples added in tandem (71 and 100). Interestingly, the relative 
fluorescence of all the samples containing both Fe complexed HA and HA (61 -
100) were significantly greater than those of samples containing Fe complexed 
HA alone (49) . This suggests that some crosslinking between the polyanionic 
HA chains was occurring , leading to a greater amount of carbohydrate binding 
per CD44 receptor. We hypothesize that region of the crosslinked 
polysaccharide that binds to the receptor is the region with the lowest Fe content. 
Table 10. Competition Assay. 
Labeled Single Materials Materials added 
Material * material incubated simultaneously 
added together 
HA 92 88 100 
Fe-HA 49 61 71 
* Hyaluronic aCid samples with or without Iron were labeled with biotin . 
Experimental conditions were as described in Section 2.0.5. 
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4. Conclusion 
4.A. Assay Development: Optimized Protocol 
4.A. 1. Optimization of Cell Culture 
The assay development process led to an optimized protocol for use with 
human mesothelioma cells and biotinylated HA. Experimentally, we determined 
that trypsinization of the cells resulted in a possible loss of CD44 receptors from 
the cell surface. As a result , cell scraping was used for gentle removal of the 
cells from the culture substrate. However, scraping resulted in cell clumping 
which gave rise to uneven growth on the culture dish. Future assays will be 
conducted to determine the duration of incubation necessary after trypsinization 
that allows for re-expression of the CD44 cell surface receptor. 
Cell based assays showed that high cell confluence gave rise to a 
decrease in fluorescence intensity. Cell confluence at 20-30%, observed after a 
24 hour incubation period , resulted in the highest fluorescence intensities. When 
confluence was low, the exposed cell surface area was high, and thus more 
receptors were available to bind to target molecules. 
4.A.2. Optimization of Cell-Based Assays 
Adequate well washings after incubation with reagents was necessary for 
removal of residual reagents. We determined that washing wells for 3 minutes in 
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PBS (x3) gave acceptably low background fluorescence. Additionally, we 
experimentally showed that results did not vary between those cells that were 
fixed and those that were not. Specifically, cell fixing maintained the CD44-
biotinylated HA association while not interfering with subsequent avidin-
fluorescein binding . These results validated the use of cell fixation in long assays 
for which cell viability could be problematic. 
4.A.3. Optimization of HA Binding 
Although CD44 receptors are known for their affinity for HA, it was not 
previously known if modification of HA would affect that affinity. We discovered 
that biotinylation of HA did not affect the association. This confirmed that avidin-
biotin association could be exploited to detect HA and HA-Fe binding to CD44. 
4.B. Competition Assay 
Competition assays were conducted to determine the effects of iron(lIl) on 
HA binding by CD44 receptors (Sections 2.0.5 and 3.A.7) . CD44 receptors 
expressed by human mesothelioma cells were shown to bind both biotinylated 
HA and biotinylated FE complexed HA. Iron was shown to partially quench 
fluorescence of the biotinylated Fe complexed HA avidin-fluorescein conjugate, 
complicating interpretation of the results. Combining the results of the 
fluorescence quenching experiments with the biotinylated HA and biotinylated Fe 
complexed HA experiments , it appears that iron slightly inhibits HA binding. 
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Specifically, when corrected for quenching effects , the fluorescence observed 
with biotinylated Fe complexed HA binding experiments is still significantly lower 
than that observed with biotinylated HA. 
While biotinylated HA binding was partially blocked by pre-treatment of the 
cells with an anti-CD44 antibody, such treatment fully blocked binding of 
biotinylated Fe complexed HA. This result suggests that biotinylated Fe 
complexed HA may be binding to a subset of CD44 receptors that are blocked by 
the antibody, while the biotinylated HA is bound by a larger set of receptors. 
Polyanionic HA molecules have been shown to bind metal cations , 
presumably causing changes in conformation , and possibly crosslinking the 
normally linear HA chains 15,31 . Results of these assays were not consistent with 
a simple competitive binding model (i .e., a model where either HA or Fe 
complexed HA is bound to a given receptor) . While added Fe complexed HA did 
not compete to diminish biotinylated HA binding , added HA served to increase 
biotinylated Fe complexed HA binding. This result suggests that incubation of Fe 
complexed HA with biotinylated HA or incubation of HA with biotinylated Fe 
complexed HA results in crosslinking of the HA molecules. In this scenario , both 
HA and biotinylated HA are crosslinked by iron and the resulting complex is 
anchored to the receptor. Since both samples are attached , additional 
fluorescence is observed in the case of the biotinylated Fe complexed HA 
binding . 
46 
4.C. Future Experimentation 
Future experimentation will seek to confirm quenching of the fluorophore 
by iron . If quenching is confirmed. other methods of detection will be employed. 
Additionally, the concentration of HA necessary to saturate the receptors will 
need to be elucidated . Titration experiments with biotinylated HA can provide 
this information. 
Long term experiments will aim to confirm the formation of a crosslinked 
complex. Incubation of biotinylated samples of HA and Fe complexed HA would 
give rise to an increase in fluorescence signal if a crosslin king reaction is 
occurring . Additionally, depolymerized Fe complexed HA samples will pass 
through a 0.45 IJm microspin column if no crosslinking is occurring. Conversely, 
crosslinked samples will not pass through the same filter. An experiment will be 
conducted in which incubated depolymerized Fe complexed HA is centrifuged in 
a microspin column. Confirmation of crosslinking will be made using EI-MS. 
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